Schröder R, Williams B T, Fischer A B. "一种的合成方法" [P]. US Patent, US 11973801 B2, 2016-08-03.
发明人高志强,胡光,杨光. "Method for the Synthesis of [5-(3,4-Dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl imidothiocarbamate hydrochloride" [P]. 中国发明专利, 专利号 CN 114547794 B, 授权公告日 2025-07-07.
发明人杨光,高志强,黄志刚. "A Process for Preparing High-Purity [5-(3,4-Dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl imidothiocarbamate hydrochloride" [P]. 中国发明专利, 专利号 CN 114627971 A, 授权公告日 2022-06-03.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2013, 671, (12), 3424-3448.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2023, 2282, (4), 2204-2229.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of [5-(3,4-Dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl imidothiocarbamate hydrochloride Using HRMS and NMR". J. Pharm. Biomed. Anal., 2016, 625, (5), 832-845.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2021, 947, (9), 6149-6177.